/Companies

Illustris Pharmaceuticals

Palo Alto, US · Founded 2016 · Delaware corporation

Find your way into Illustris Pharmaceuticals

Sign up to see every warm intro you have to Illustris Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Illustris Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

JL
Jaehoon LeeExecutive
MP
Mark PrygockiExecutive
GVGloria Vasquez
Gloria VasquezExecutive
JM
Jacob M. WaughNamed on SEC filing

Board

SK
Siak Khim TanBoard director
AH
Andrew HirschbergBoard director
JS
Jonah ShacknaiBoard director

Reported raises · per SEC filings

Form D private placements

$5M disclosed across 1 round · 2016

▶$5MraisedMar 2017 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew HirschbergDirector
  • Jonah ShacknaiDirector
  • Jaehoon LeeExecutive Officer
  • Mark PrygockiDirector, Executive Officer
  • Jacob M. WaughExecutive Officer, Director
  • Siak Khim TanDirector
  • Gloria VasquezExecutive Officer
Offering amount
$5M
Amount sold
$5M
First sale
Dec 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Illustris Pharmaceuticals raised?
Illustris Pharmaceuticals has disclosed $5M raised across 1 round.
Where is Illustris Pharmaceuticals headquartered?
Illustris Pharmaceuticals is headquartered in Palo Alto, US.